The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

The University of Texas MD Anderson Cancer Center, Houston, Texas